2021 MIPS Measure #180: Rheumatoid Arthritis (RA): Glucocorticoid Management 

Measure Type High Priority Measure? Collection Type(s)
Process no MIPS CQM

 

Measure Description

Percentage of patients aged 18 years and older with a diagnosis of rheumatoid arthritis (RA) who have been assessed for glucocorticoid use and, for those on prolonged doses of prednisone ≥ 10 mg daily (or equivalent) with improvement or no change in disease activity, documentation of glucocorticoid management plan within 12 months.